iver sub-15-minute diagnostics with actionable results in six to eight minutes. Patented XCR-detection chemistry combines with a reagent system that uses rapid sample preparation and amplification to deliver rapid results. CEO Bill Olson says his technology is “compatible with existing PCR instruments,” and anticipates “XCR accelerating turnaround time at POC at five- to 10-times the speed of traditional PCR.”


Don't miss the BIOMEDevice San Jose conference and expo, December 2-3, 2015. |